SymPhysis Medical: Patient-Centric Care for Pleural Effusion

article image

Malignant pleural effusion is a side effect of several prevalent cancers that causes fluid to accumulate in the chest cavity, limiting the expansion of the lungs and causing breathlessness, anxiety, and chest pain. While some drainage devices exist to alleviate this condition, SymPhysis Medical has engineered the first device that patients can use autonomously, restoring independence to their life.

The city of Galway, Ireland is a known hotbed of medtech business development and is home to a multitude of innovative medical device companies including SymPhysis Medical Ltd., a start-up with a patient-centric solution to malignant pleural effusion (MPE). MPE is a complication associated with cancers of the thorax area such as breast and lung cancer, mesothelioma, and lymphoma, occurring in roughly 15% of combined cases and 50% of all metastatic cancers.


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: